Global Bioresorbable Polymers Market Size Study, By Product (Polysaccharides, Proteins, Polylactic Acid, Polyglycolic Acid, Polycaprolactone), By Application (Orthopedics, Drug Delivery, Others), and Regional Forecasts 2022-2032
The Global Bioresorbable Polymers Market was valued at approximately USD 448.03 Million in 2023 and is projected to grow at an impressive CAGR of 11.6% over the forecast period of 2024–2032. These advanced polymers, engineered to degrade safely within the body, are revolutionizing healthcare applications, particularly in orthopedics and drug delivery. By eliminating the need for surgical removal, bioresorbable polymers enhance patient recovery and optimize clinical outcomes.
Rising awareness of healthcare solutions, coupled with an increase in surgical procedures worldwide, is driving the demand for bioresorbable polymers. Globally, approximately 310 million major surgeries are conducted annually, with a significant portion requiring materials like sutures, tissue scaffolds, and implants made from bioresorbable polymers. Furthermore, advancements in materials such as polylactic acid (PLA) and polyglycolic acid (PGA) are enhancing the capabilities of these polymers in applications ranging from drug delivery to regenerative medicine.
The growing preference for minimally invasive procedures has catalyzed innovations in bioresorbable drug delivery systems, including microspheres and nanofibers. These systems provide controlled drug release, reducing the need for frequent interventions and improving therapeutic efficacy. Additionally, the increasing adoption of bioresorbable implants in orthopedic surgeries for conditions like degenerative joint diseases and osteoporosis underscores their expanding role in medical advancements.
North America dominated the market in 2023, driven by extensive research and development activities and robust healthcare infrastructure. However, Asia Pacific is anticipated to witness the fastest growth, fueled by an aging population, rising healthcare expenditures, and increasing investments in advanced medical technologies. Countries such as China and India are emerging as key players in the adoption of bioresorbable polymers due to their expanding healthcare sectors.
Major market players included in this report are:
• Corbion NV
• Evonik Industries AG
• Poly-Med Inc.
• Foster Corp.
• Abbott
• KLS Martin Group
• 3D Biotek LLC
• Sunstar Suisse S.A.
• DSM
• Futerro
• Shalby Advanced Technologies
• Gardner Orthopedics
• JeNaCell
• Organogenesis Holdings
• Stryker Corporation
The detailed segments and sub-segments of the market are explained below:
By Product
• Polysaccharides
• Proteins
• Polylactic Acid (PLA)
• Polyglycolic Acid (PGA)
• Polycaprolactone
• Others
By Application
• Orthopedics
• Drug Delivery
• Others
By Region:
• North America
U.S.
Canada
• Europe
U.K.
Germany
France
Italy
Spain
The Netherlands
Poland
• Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Indonesia
Malaysia
• Central & South America
Brazil
Argentina
• Middle East & Africa
Saudi Arabia
South Africa
UAE
________________________________________
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways
• Market Estimates & Forecast for 10 years from 2022 to 2032
• Annualized revenues and regional-level analysis for each market segment
• Detailed analysis of geographical landscape with country-level analysis of major regions
• Competitive landscape with information on major players in the market
• Analysis of key business strategies and recommendations on future market approach
• Demand-side and supply-side analysis of the market
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- Chapter 1: Global Bioresorbable Polymers Market Executive Summary
- 1.1. Market Size & Forecast (2022–2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Application
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendations
- Chapter 2: Global Bioresorbable Polymers Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.4. Estimation Methodology
- Chapter 3: Global Bioresorbable Polymers Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Increasing Demand for Surgical Implants
- 3.1.2. Technological Advancements in Drug Delivery
- 3.1.3. Rise in Geriatric Population
- 3.2. Market Challenges
- 3.2.1. High Costs of Manufacturing
- 3.2.2. Limited Awareness in Emerging Markets
- 3.3. Market Opportunities
- 3.3.1. Growth Potential in Asia Pacific and Latin America
- 3.3.2. Innovations in Biodegradable Polymers
- Chapter 4: Global Bioresorbable Polymers Market Industry Analysis
- 4.1. Porter’s Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Key Winning Strategies
- Chapter 5: Global Market Size & Forecast by Product (2022–2032)
- 5.1. Polysaccharides
- 5.2. Proteins
- 5.3. Polylactic Acid (PLA)
- 5.4. Polyglycolic Acid (PGA)
- 5.5. Polycaprolactone
- 5.6. Others
- Chapter 6: Global Market Size & Forecast by Application (2022–2032)
- 6.1. Orthopedics
- 6.2. Drug Delivery
- 6.3. Others
- Chapter 7: Global Market Size & Forecast by Region (2022–2032)
- 7.1. North America
- 7.1.1. U.S.
- 7.1.2. Canada
- 7.1.3. Mexico
- 7.2. Europe
- 7.2.1. U.K.
- 7.2.2. Germany
- 7.2.3. France
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. The Netherlands
- 7.2.7. Poland
- 7.3. Asia Pacific
- 7.3.1. China
- 7.3.2. Japan
- 7.3.3. India
- 7.3.4. Australia
- 7.3.5. Thailand
- 7.3.6. South Korea
- 7.3.7. Indonesia
- 7.3.8. Malaysia
- 7.4. Central & South America
- 7.4.1. Brazil
- 7.4.2. Argentina
- 7.5. Middle East & Africa
- 7.5.1. Saudi Arabia
- 7.5.2. South Africa
- 7.5.3. UAE
- Chapter 8: Competitive Intelligence
- 8.1. Key Company SWOT Analysis
- 8.1.1. Evonik Industries AG
- 8.1.2. Corbion NV
- 8.1.3. Abbott
- 8.2. Market Strategies
- Chapter 9: Research Process
- 9.1. Data Mining
- 9.2. Analysis
- 9.3. Market Estimation
- 9.4. Validation
- 9.5. Publishing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook